Vistra's AI Power Story Is Still About Execution, Not Demand

What happened

Vistra remains a favorite proxy for AI-driven power demand, but a new Motley Fool ranking places it behind peers, while the company's own disclosures reveal the real story is about execution timing, not lack of demand. The company's latest filings show signed 20-year PPAs with Meta and AWS, strong PJM capacity auction results, and a reaffirmed 2026 EBITDA guidance, but ERCOT monetization is slipping into 2027-2028 due to regulatory verification delays. At a recent price near $147, Vistra trades at 24.5x earnings and 13.2x EV/EBITDA, leaving little margin of safety relative to a base-case fair value of $155 and an attractive entry of $135. The critical near-term catalysts are closing the Cogentrix acquisition by year-end 2026 and starting Meta power deliveries on schedule, both of which management currently expects but have not yet delivered. Meanwhile, the AI power narrative remains intact but increasingly conditional, as market coverage shifts from enthusiastic demand forecasts to questions about interconnection bottlenecks and price realization.

Implication

Investors should recognize that the AI power tailwind is real but delayed for Vistra, making the stock a 'show me' story rather than a pure momentum trade. The base case of $155 per share implies only modest upside from current levels, while the bear case of $125 is uncomfortably close if Texas verification stalls further or Cogentrix slips into 2027. Given the trimmed WAIT rating and the gap between price and intrinsic value, initiating a new position is unattractive, but existing holders can hold for the contracted PJM earnings and buyback support. A more attractive entry below $135 would provide a clearer reward-to-risk balance, especially if management delivers on its 2026 catalysts. Until then, monitor 90-day checkpoints: Cogentrix legal close, Pulaski solar COD, and any signs of ERCOT Batch Zero conversion to verified load.

Thesis delta

The new article does not change the thesis; it merely rehashes the widely known AI power demand angle without addressing execution hurdles. The deep value report's WAIT rating stands, as the stock's current price already embeds smooth delivery of Cogentrix and contracted PPAs, leaving insufficient margin of safety. No adjustment to entry or trim levels is warranted at this time.